Doctor’s Blog
Dr. David W. Goodman helps Readers Digest with Myths of ADHD
Despite decades of articles on the science and research of ADHD, it never ceases to amaze me when I have a conversation with people who don’t believe in ADHD. While I understand concerns of “the label” and “bad medicine”, I have seen thousands of patients who, when treated for the first time in adulthood, say […]
Dr. David W. Goodman ADHD in older adults U.S. News and World Report March 2016
Since the recent publication of our literature of published research on ADHD in adults over age 50, several news outlets have been interested in bring this subject to the public eye. ADHD in adults persists throughout one’s life. It does not go away because you got your AARP card or Medicare benefits. Because I believe […]
Dr. David W. Goodman interviewed by WOSU (NPR) on Adult ADHD January 26, 2016
It appears that the topic of ADHD in older adults is catching some attention. I was invited by Ann Fisher of WOSU Radio (NPR affiliate) in Columbia, Ohio to discuss adult ADHD especially in older adults. The host, Ann, asked insightful questions about identification and diagnosis in older adult and how that’s different from younger adults […]
Insurance companies restrict psychiatric medications for this patient Part 2
In my previous blog, I wrote, in general, about the increasing obstacles set up by insurance companies to restrict psychiatric medications to patients. Today, I’ll tell you a specific example of how a medication dosing thoughtful established for a patient was denied despite both clinical and research evidence to support my dosing recommendations. My patient […]
Insurance companies restrict psychiatric medications for patients Part 1
With each passing year, insurance companies are instituting contractual clauses in benefit packages that restrict psychiatric medications for patients. Specifically, this comes in the form of prior authorization for stimulant medications, despite FDA approval of these medications for ADHD. Combine the prior authorization process with changes in drug formularies (a tiered list of medications that an […]
National Public Radio (NPR) interviews Dr. David W. Goodman on ADHD in older adults
ADHD in adults has now been recognized by clinicians for many years now. However, ADHD in older adults has received almost no attention because research has limited its work to those people under the age of 50. There is a body of research developing in older adults and I recently published with my colleagues a […]
American Professional Society for ADHD and Related Disorders 2016 conference speaker videos
American Professional Society for ADHD and Related Disorders has posted videos by many of the speakers at this year’s conference. For those professionals and others who are interested in the covered topics, we can listen the 5 min videos descriptions by the speakers of their topics. My video about ADHD in older adults is included. […]
ADHD in older adults: First published review of world-wide literature
On December 16, 2015, our article reviewing the world’s English scientific literature on ADHD in adults over age 50 years was published online in Drugs and Aging, an international journal. While there is a paucity of research, there are enough publications to merit pulling this literature together into one paper. Most of research comes out […]
Dr. David W. Goodman to speak at the American Professional Society for ADHD and Related Disorders in Washington, DC on January 16, 2015.
This Society is an internationally represented organization of ADHD researchers and clinicians whose goal is to discuss and disseminate the state-of-the-art in ADHD diagnosis and treatment. I am honored to be invited to present my findings from our publication on ADHD in adults over age 50. The link is brief interview highlighting our upcoming discussion […]
Medication helps ADHD but less so for Executive Function
The use of medication in treating ADHD is highly recommended by many professional organizations who focus on ADHD (American Academy of Pediatrics, American Academy of Child and Adolescent Psychiatry, American Psychiatric Association) to name a few U.S. organizations. However, ADHD medications’ effects may be specific to inattention, distractibility, impulsivity, and restlessness and much less helpful […]